The study will determine if the Fragmin dose can be adjusted to suit the clinical needs of
patients during dialysis.
- chronic renal failure on hemodialysis
- significant comorbidities that would prevent a patient from completing the trial
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center
Pfizer Clinical Trials Contact Center
call now email
Contact a representative by phone, email, or visiting the study website. Please see the references below: